The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2008

Filed:

Jun. 06, 2005
Applicants:

Daniel Cohen, Le Vézinet, FR;

Marta Blumenfeld, Paris, FR;

Ilya Chumakov, Vaux-le Penil, FR;

Lydie Bougueleret, Petit-Lancy, CH;

Bernard Bihain, Cancale, FR;

Laurent Essioux, Paris, FR;

Inventors:

Daniel Cohen, Le Vézinet, FR;

Marta Blumenfeld, Paris, FR;

Ilya Chumakov, Vaux-le Penil, FR;

Lydie Bougueleret, Petit-Lancy, CH;

Bernard Bihain, Cancale, FR;

Laurent Essioux, Paris, FR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 2/00 (2006.01); C07K 4/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention concerns the human sbg1, g34665, sbg2, g35017 and g35018 genes, polynucleotides, polypeptides biallelic markers, and human chromosome 13q31-q33 biallelic markers. The invention also concerns the association established between schizophrenia and bipolar disorder and the biallelic markers and the sbg1, g34665, sbg2, g35017 and g35018 genes and nucleotide sequences. The invention provides means to identify compounds useful in the treatment of schizophrenia, bipolar disorder and related diseases, means to determine the predisposition of individuals to said disease as well as means for the disease diagnosis and prognosis.


Find Patent Forward Citations

Loading…